Panel Discussion: Discussing the Potential Impact of GLP-1 Coverage on State & Federal Budgets & Healthcare Systems
Time: 2:00 pm
day: Conference Day One
Details:
- Highlighting the prevalence of diabetes and obesity in lower income families that rely on public healthcare systems
- Discussing the potential for AOMs to improve public health outcomes and reduce the long-term costs of treatment associated with the end-stage results of obesity such as MASH and heart disease
- Understanding the direct cost of GLP-1 coverage per member considering coverage tiers, utilization rate and pharmaceutical spend
- Examining strategies such as value-based pricing agreements and manufacturer negotiations to reduce cost and add value too state decision makers
